Education
Dynlacht earned a Bachelor of Science in 1987 from, where he first conducted research under the mentorship of Paul Howard-Flanders. He was awarded a Doctor of Philosophy in Biochemistry in 1992 from the University of California at Berkeley. As a graduate student with Robert Tjian, Dynlacht and Timothy Hoey first discovered and functionally characterized TFIID. Dynlacht carried out postdoctoral studies with Editor Harlow at the Massachusetts General Hospital, where he definitively proved for the first time, in vitro using purified proteins, the biochemical mechanism through which transcription can be directly repressed by the Rb tumor suppressor protein.
This study also provided the first example of an in vitro transcription system that responds to regulatory events acting upstream of the binding of a transactivator.
Dynlacht was appointed to the position of Assistant professor in the Department of Molecular and Cellular Biology at Harvard University in 1995 and then associate professor in 1999.
He is currently a Professor in Pathology in the Laura and Isaac Perlmutter Cancer Center of the New York University School of Medicine.